Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|July 2, 2021
α/β-Hydrolase Domain (ABHD) Inhibitors as New Potential Therapeutic Options against Lipid-Related DiseasesGiulia Bononi, Tiziano Tuccinardi, Flavio Rizzolio, et al.
Molecules (Basel, Switzerland)|April 29, 2020
Application of MM-PBSA Methods in Virtual ScreeningGiulio Poli, Carlotta Granchi, Flavio Rizzolio, et al.
Journal of Hematology & Oncology|June 22, 2018
Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacyFederico Rossari, Filippo Minutolo, Enrico Orciuolo
European Journal of Medicinal Chemistry|September 28, 2011
N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferationCarlotta Granchi, Sarabindu Roy, Alessio De Simone, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 11, 2018
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancerConcetta Russo Spena, Lucia De Stefano, Stefano Palazzolo, et al.
Cell Metabolism|September 4, 2018
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted TherapiesMaria Apicella, Elisa Giannoni, Stephany Fiore, et al.
European Journal of Medicinal Chemistry|October 12, 2020
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitorsCarlotta Granchi, Giulia Bononi, Rebecca Ferrisi, et al.
Journal of Medicinal Chemistry|January 9, 2018
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) InhibitorsMojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
Pageof 16